EpiBone Pipeline
| Drug | Indication | Phase |
|---|
| EB-cMF | Craniofacial defects from trauma, congenital defect, or degenerative bone disease | Phase 1/IIa Completed |
| EB-OC | High-grade osteochondral lesions in joints | Phase I/IIb |
| EB-iAC | Low-grade cartilage lesions in joints | Pre-clinical |